DRAXXIN®

Treatment and prevention of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis susceptible to tulathromycin. The presence of the disease in the herd should be established before preventative treatment. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis susceptible to tulathromycin.

2.5 mg tulathromycin /kg (1ml/40kg.) body weight (BW). A single subcutaneous injection. For treatment of cattle over 300 KG body weight, divide the dose so that no more than 7.5 ml are injected at one site.

Do not use in case of hypersensitivity of the target animals to macrolide antibiotics. Do not use the product simultaneously with other macrolides or lincosamides. Do not use in lactating cattle producing milk for human consumption. Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition.

Shelf life after first opening the container: 28 days. Do not use this veterinary medicinal product after the expiry date which is stated on the label. Keep out of the sight and reach of children. Store below 30 C.